GSK China’s bribery scandal resolved with heavy sentence

A few months ago, GlaxoSmithKline was shamefaced with its scandal in China, involving embezzlement of public property and bribery to then deputy health commission chief, Dr. Fengping Huang. A majority of hospitals in China are state-run and are financially, minimally supported by the government. To supplement their unsatisfactory income, doctors often accept a sum to prioritize patients who require expensive …